Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
Sunflower Therapeutics is a biotech company that delivers next-generation protein manufacturing solutions.
Omniose is an early stage biotechnological company.
Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.
Scanogen is a molecular diagnostic company.
Ceramedix Holding is a biotherapeutics company that develops antibody-based drugs with the aim of addressing novel diseases.
Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections.
IBBR is leverages state-of-art integrative methods for bioanalytical, biophysical and structural characterization of biomolecules.
Acenxion Biosystems is a privately funded company developing automated medical diagnostic systems for precision medicine.
Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
Melax Technologies specializes in machine learning, software, domain, natural language processing and medical coding services.
Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
Clairyon is a healthcare technology company that specializes in outpatient monitoring, predictive analytics, and quality reporting services.
MiNK Therapeutics is a biopharmaceutical company developing allogeneic iNKT cell therapies and immune technologies for treatment.
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs
Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines
Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.
Truly Technologies develops biospecimen processing technologies for diagnostic, therapeutic and life science research applications.
ReAlta is a clinical-stage biotech company that develops a new class of drugs to address life-threatening diseases.
TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.
Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.
National Institute of Allergy and Infectious Diseases has invested in 64 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institute of Allergy and Infectious Diseases's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 21 different industry categories.
Among tracked funding rounds, ILiAD Biotechnologies received $115.0M in a Series D round. National Institute of Allergy and Infectious Diseases's total known invested capital is $149.3M.
National Institute of Allergy and Infectious Diseases's average investment size is $2.8M across its portfolio of 64 companies.
Recent National Institute of Allergy and Infectious Diseases portfolio additions include Lactiga, Sunflower Therapeutics, Omniose, Resvita Bio, Scanogen. These companies were founded in 2020 or later.